There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Learn about the latest vector delivery systems for gene therapies and their role in enhancing efficacy and safety. Understand the critical steps involved in translating laboratory research into ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

Jason Foster, CEO of Ori Biotech, discusses the difficulties preventing more widespread adoption of these advanced therapies.

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

Taysha Gene Therapies offers hope for Rett syndrome with innovative treatment, strong trial results, and promising regulatory ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...